Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

AstraZeneca and Veeva: reducing disruption from the Covid-19 pandemic

The Covid-19 pandemic has challenged all industries, and pharma is no exception, with some clinical trials struggling to continue as normal. To this end, pharma companies like AstraZeneca, and the vendors that support them, such as Veeva, have implemented remote monitoring to allow clinical trials, including those for potential Covid-19 treatments, to continue with as little disruption as possible.

Close
Close
Close

Go Top